Remove tag clinical-trial-recruitment
article thumbnail

CHMP backs J&J’s myeloma bispecific Tecvayli, ahead of US decision

pharmaphorum

It showed an overall response rate with Tecvayli of 63%, including 39% complete responses which is a remarkable result given that the patient recruited into the trial were very ill and heavily pre-treated. Tecvayli previously scored a priority medicines (PRiME) designation from the EMA and a breakthrough-therapy tag from the FDA.

article thumbnail

How to Become a Medical Sales Rep & Build a Successful Career As One

Map My Customers

Surgical Equipment Sales - This type of rep will be selling specialized surgery equipment that often comes with a high price tag. Recruiters will value the fact that other people in medical sales know and trust you. It does feature both direct and recruiter-posted openings for entry-level and experienced medical sales reps.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How data is crucial to the relaunch of the Cancer Moonshot

pharmaphorum

During the first stage of the initiative, more than 2,000 research papers were published, 49 clinical trials were carried out, and more than 30 patents were filed through the support of the US National Cancer Institute (NCI). These datasets are critical as a means to identify how molecular information affects clinical outcomes.”

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

“Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% One highly anticipated study is Mounjaro’s SURMOUNT-MMO Phase III clinical trial. billion in 2022 alone to expand capacity.

Medical 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

“Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% One highly anticipated study is Mounjaro’s SURMOUNT-MMO Phase III clinical trial. billion in 2022 alone to expand capacity.

Medical 98